First Time Loading...

Neurotech International Ltd
ASX:NTI

Watchlist Manager
Neurotech International Ltd Logo
Neurotech International Ltd
ASX:NTI
Watchlist
Price: 0.078 AUD 4% Market Closed
Updated: May 16, 2024

Neurotech International Ltd
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Neurotech International Ltd
Operating Income Peer Comparison

Comparables:
IPD
C
CYC
COH
OIL
EMV

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Neurotech International Ltd
ASX:NTI
Operating Income
-AU$5m
CAGR 3-Years
-6%
CAGR 5-Years
-6%
CAGR 10-Years
N/A
ImpediMed Ltd
ASX:IPD
Operating Income
-AU$20.7m
CAGR 3-Years
0%
CAGR 5-Years
4%
CAGR 10-Years
-12%
C
Cyclopharm Ltd
ASX:CYC
Operating Income
-AU$8.6m
CAGR 3-Years
-16%
CAGR 5-Years
-119%
CAGR 10-Years
-25%
Cochlear Ltd
ASX:COH
Operating Income
AU$491.1m
CAGR 3-Years
36%
CAGR 5-Years
6%
CAGR 10-Years
15%
Optiscan Imaging Ltd
ASX:OIL
Operating Income
-AU$5.7m
CAGR 3-Years
-66%
CAGR 5-Years
-21%
CAGR 10-Years
-11%
EMvision Medical Devices Ltd
ASX:EMV
Operating Income
-AU$3.8m
CAGR 3-Years
2%
CAGR 5-Years
-35%
CAGR 10-Years
N/A

See Also

What is Neurotech International Ltd's Operating Income?
Operating Income
-5m AUD

Based on the financial report for Dec 31, 2023, Neurotech International Ltd's Operating Income amounts to -5m AUD.

What is Neurotech International Ltd's Operating Income growth rate?
Operating Income CAGR 5Y
-6%

Over the last year, the Operating Income growth was 2%. The average annual Operating Income growth rates for Neurotech International Ltd have been -6% over the past three years , -6% over the past five years .